The digital health world showed real signs of market traction the first half of this year, with new companies in space raising $ 6.4 billion in risk capital funds, according to a report published by rock Health on Monday.
The total financing of digital health startups, the first half of 2025 is a little more than $ 6.2 billion and $ 6 billion than the thesis startups collected in the first halves of 2023 and 2024, respectively. This indicates a stable market that has discovered how its new normality seems after an boom in the Pandemia, said the report.
The new companies centered in AI captured 62% of all digital health risk funds in the first half of the year, raising an average of $ 34.4 million per round, which is an 83% premium on the peers that are not AI, according to the report. Most of these AI companies made products to improve clinical workflows, non -clinical administrative tasks and data infrastructure.
Of the 11 megadeals financing for a total of $ 100 million or more, which were closed for the duration of digital health startups, the first half of 2025, nine were collected by companies focused on AI. For example, the Startup of Clinical Documentation Abridge raised $ 250 million in February and another $ 300 million in June. Other new AI companies, including innovation, Hipcratic AI, Qventus and Truveta, all closed rounds of more than $ 100 million.
The report said that suppliers are also quickly adopting some of the tools.
For AI tools that address things such as environmental documentation and medical reference platforms, some hospitals report use rates of up to 90%, which is a surprising change given the past resistance of suppliers to the new technology, according to the report. He also said that new AI companies are the confidence of ear suppliers through the delivery of products that are more intuitive, implementing tools more broadly in existing technological infrastructure and generating measurable results.
In addition to the thousands of millions that flow to the suppliers of AI, the first half of 2025 also presented the long -awaited OPI of the hinge health and the health departures that many felt they were behind, after years of stagnation. The report indicated that the thesis companies spent in a decade creating confidence, refining their models of attention and deploying AI to provide scalable care.
The public debuts of the hinge and bove could mark the beginning of a more mature digital health market, which can help rekindle investors’ confidence, as well as prepare the scenario for future health and healthier investment cycles.
While public offers draw the headlines, the report said that most new digital health companies are dating M&A, with 107 of this type in the first half of 2025, which Pich put pace almost twice as of 2024.
Private capital companies are also feeding consolidation by combining inherited health businesses with new AI native companies. They are betting that these roll-ups will allow greater efficiency and scale, according to the report.
Amid the promising output environment and an increasingly fast rhythm of the adoption of AI, digital health companies also face a growing policy and economic uncertainty, participating with respect to the recent approval of a great Big Beautiful Bill law. The medical work requirements of the invoice and the changes in the ACA markets could leave millions of people without insurance, reduce the directionable market and exacerbate the financial tension of the suppliers.
To navigate the thesis changes, rock Health encouraged new digital health companies to participate early with federal initiatives and try to align with priorities such as chronic diseases and the benefit of care.
Photo: Ta now, Getty Images